Ewa Golańska

Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic

Matthias Schmitz, Elisabeth Ebert, Katharina Stoeck et al. · Molecular Neurobiology · 2015 · 101 citations

14-3-3 Protein, Creutzfeldt-jakob Disease, Medicine +7

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

Inga Zerr, Matthias Schmitz, André Karch et al. · Alzheimer s & Dementia · 2018 · 98 citations · Full text

Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

Emma Jones, Holger Hummerich, Emmanuelle Viré et al. · The Lancet Neurology · 2020 · 71 citations · Full text

Genome-wide Association Study, Disease Susceptibility, Sporadic Creutzfeldt-jakob Disease +12

Evaluation of α‐synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases

Franc Llorens, Niels Kruse, Matthias Schmitz et al. · Alzheimer s & Dementia · 2016 · 61 citations

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.

Iga Wójcik, Małgorzata Szybka, Ewa Golańska et al. · PubMed · 2005 · 50 citations

Engineering, Mixed-phenotype Acute Leukemia, Pathology +18